We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Search for information about medicines including patient information leaflets (PILs), details on how the medicine can be used (SmPCs) and scientific reports (PARs).
Guidance and information on integrated care.
Apply for an import certificate to import a medicinal product into the UK for veterinary use.
Information about when you need to submit substantial amendments to a clinical trial including changes to the trial sponsor or legal representative, Investigational medicinal product certification and importation.
Guidance for prescribing vets on the use of the cascade.
The process for the simultaneous review of veterinary medicine submissions by Switzerland’s Swissmedic and the UK's Veterinary Medicines Directorate.
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
Information for wholesale dealer licence holders about the medicines put on the UK market for UK patients that they cannot export or hoard.
Apply for a promising innovative medicine (PIM) designation or scientific opinion for your medicine from MHRA.
Guidance for veterinary medicines manufacturers and wholesale dealers in GB on selling and supplying products placed on the EU and UK markets before 1 January 2021 and the evidence you may need to provide.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
The actions to take for sourcing medicines in different circumstances.
Guidance for industry on flexible approaches we are taking on good distribution practices.
How to get a parallel import licence for your medicine in the UK, including pharmacovigilance requirements and submitting your application.
The MHRA is part of the Access Consortium along with the Therapeutic Goods Administration, Health Canada, Health Sciences Authority of Singapore and Swissmedic.
Actions that trial sponsors should consider to build resilience into clinical trial design
How to comply with the requirements on promoting medicines to the public and to prescribers and suppliers of medicines.
How to apply for simultaneous review of veterinary medicine submissions to the Australian Pesticides and Veterinary Medicines Authority (APVMA) and the VMD.
Details of the process changes for established medicines, effective from 1 March 2024, which apply specifically to chemical products.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).